Showing results (11-20 of 49) with videos related to
Sort By:
Pageof 5
Cancer Biomarkers : Section a of Disease Markers|May 16, 2018
Reduced expression of Rap1GAP as a prognostic biomarker for primary gastric cancer patientsJingjing Zhao, Cong Mai, Desheng Weng, et al.International Journal of Cancer|December 15, 2010
Induction of cytotoxic T lymphocytes against ovarian cancer-initiating cellsDesheng Weng, Baizheng Song, John Durfee, et al.BMC Cancer|November 1, 2024
Efficacy and safety of surufatinib in the treatment of patients with neuroendocrine tumor: a real-world study in Chinese populationYuanyuan Liu, Xinyi Yang, Yan Wang, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 2, 2009
A heat shock protein 70-based vaccine with enhanced immunogenicity for clinical useJianlin Gong, Yunfei Zhang, John Durfee, et al.Oncotargets and Therapy|May 16, 2018
A favorable outcome of advanced dermatofibrosarcoma protuberans under treatment with sunitinib after imatinib failureWei Xiao, Yi Que, Ruiqing Peng, et al.Molecular Cancer Therapeutics|August 20, 2024
Targeting PDHK1 by DCA to Restore NK Cell Function in Hepatocellular CarcinomaXinyi Yang, Yuanyuan Liu, Peng Wang, et al.Breast Cancer Research : BCR|September 18, 2010
Radiosensitization of mammary carcinoma cells by telomere homolog oligonucleotide pretreatmentDesheng Weng, Monique C Cunin, Baizheng Song, et al.Molecular Cancer|July 15, 2010
Extensive analysis of D7S486 in primary gastric cancer supports TESTIN as a candidate tumor suppressor geneHaiqing Ma, Desheng Weng, Yibing Chen, et al.Frontiers in Immunology|November 28, 2022
Adjuvant alternative cytokine-induced killer cell combined with natural killer cell immunotherapy improves the prognosis of post-mastectomy breast cancerXinyi Yang, Desheng Weng, Qiuzhong Pan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2026
Long-term results of multi-antigen stimulated cell therapy-I, alone or in combination with chemotherapy, as first-line maintenance therapy in advanced sarcoma: a multicenter, phase 1 trialXing Zhang, Bushu Xu, Qiuzhong Pan, et al.Pageof 5